Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Autor: Willem Pieter Brouwer, Servet Duran, Martijn Kuijper, Can Ince

Publikováno v: Critical Care, Vol 23, Iss 1, Pp 1-9 (2019)

Abstract Background and aims Innovative treatment modalities have not yet shown a clinical benefit in patients with septic shock. To reduce severe cytokinaemia, CytoSorb as an add-on to continuous renal replacement therapy (CRRT) showed promising res

Externí odkaz: https://doaj.org/article/aa499ed43fd743088d25aeba288876c2

Influence of Lead and Applied Singly and in Mixture with Chitosan on Tissue Accumulation of Clarias gariepinus

Autor: Mustafa Tunçsoy, Servet Duran

Publikováno v: Journal of Anatolian Environmental and Animal Sciences. 5:173-177

Clarias gariepinus was exposed to 1 ppm Pb singly and in mixture with 75 ppm chitosan (CT) and the levels of Pb in gill, liver, spleen, kidney and muscle tissues were determined after 1, 7 and 15 days. Lead accumulation increased in gill tissue compa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa0a0dd09051a7e2615e5f1df6c6bc22
https://doi.org/10.35229/jaes.690824

Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis

Autor: Willem P. Brouwer, Servet Duran, Can Ince

Publikováno v: Blood Purification, 50(4-5), 539-545. Karger
Blood purification, 50(4-5), 539-545. S. Karger AG

Background and Aims: It is currently unknown whether CytoSorb treatment for septic shock improves long-term survival beyond 28 days from intensive care unit (ICU) admission and which factors determine outcome. Methods: This was a long-term follow-up

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9218a93411844da6dba9809cf072e08f
https://pubmed.ncbi.nlm.nih.gov/33352555

Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study

Autor: Can Ince, Willem P. Brouwer, Servet Duran, Martijn Kuijper

Publikováno v: Critical Care
Critical Care, Vol 23, Iss 1, Pp 1-9 (2019)
Critical Care, 23(1):317. BioMed Central Ltd.
Critical care (London, England), 23(1):317. Springer Science + Business Media

Background and aims Innovative treatment modalities have not yet shown a clinical benefit in patients with septic shock. To reduce severe cytokinaemia, CytoSorb as an add-on to continuous renal replacement therapy (CRRT) showed promising results in c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4315f6b608463734ad9350c1f27bff9
https://pubmed.ncbi.nlm.nih.gov/31931850

Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster-randomized controlled trial

Autor: Daan Nieboer, Mostafa Mohseni, Servet Duran, A.B.J. Groeneveld, P. Van der Geest

Publikováno v: Clinical Microbiology and Infection, 23(2), 86-91. Elsevier Ltd.

Objectives We aimed to study the safety and efficacy of procalcitonin in guiding blood cultures taking in critically ill patients with suspected infection. Methods We performed a cluster-randomized, multi-centre, single-blinded, cross-over trial. Pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e320ccd7de686de4bcc931d555a75b2
https://pure.eur.nl/en/publications/995baf1a-f60c-4cb1-be4d-994d4e8dd233